Global Dengue Testing Market to Reach $740.8 Million by 2030

ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Dengue Testing Industry" - https://www.reportlinker.com/p05895944/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Dengue Testing Market to Reach $740.8 Million by 2030

In the changed post COVID-19 business landscape, the global market for Dengue Testing estimated at US$507 Million in the year 2022, is projected to reach a revised size of US$740.8 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. ELISA-Based Tests, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the RT-PCR Based Tests segment is readjusted to a revised 4.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $138.1 Million, While China is Forecast to Grow at 8.3% CAGR

The Dengue Testing market in the U.S. is estimated at US$138.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$161.3 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$100.3 Million by the year 2030.

Select Competitors (Total 12 Featured)
- Abbott Laboratories, Inc.
- Abnova Corporation
- Certest Biotec S.L.
- Euroimmun AG
- InBios International
- NovaTec Immundiagnostica GmbH
- OriGene Technologies, Inc.
- Quest Diagnostics, Inc.
- Roche Molecular Systems Inc.
- Thermo Fisher Scientific, Inc.


Read the full report: https://www.reportlinker.com/p05895944/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Dengue Testing - Global Key Competitors Percentage Market Share
in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Dengue Testing by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Dengue Testing by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 3: World 16-Year Perspective for Dengue Testing by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
ELISA-Based Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for ELISA-Based Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for ELISA-Based Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
RT-PCR Based Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for RT-PCR Based Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for RT-PCR Based Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 12: World 16-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Public Health Laboratory by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Public Health Laboratory by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Public Health
Laboratory by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 16: World Recent Past, Current & Future Analysis for
Diagnostic Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Diagnostic Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Diagnostic Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 21: World 16-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 22: World Dengue Testing Market Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2030

Table 23: World Recent Past, Current & Future Analysis for
Dengue IgG / IgM Rapid Test by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2022 through 2030 and % CAGR

Table 24: World Historic Review for Dengue IgG / IgM Rapid Test
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR

Table 25: World 16-Year Perspective for Dengue IgG / IgM Rapid
Test by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 26: USA Recent Past, Current & Future Analysis for Dengue
Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests
and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 27: USA Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 28: USA 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 29: USA Recent Past, Current & Future Analysis for Dengue
Testing by End-Use - Hospitals, Diagnostic Centers, Public
Health Laboratory and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 30: USA Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 31: USA 16-Year Perspective for Dengue Testing by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Diagnostic
Centers, Public Health Laboratory and Other End-Uses for the
Years 2014, 2023 & 2030

CANADA
Table 32: Canada Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 33: Canada Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 34: Canada 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 35: Canada Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 36: Canada Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR 1

Table 37: Canada 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

JAPAN
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 38: Japan Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 39: Japan Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 40: Japan 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 41: Japan Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 42: Japan Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 43: Japan 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

CHINA
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 44: China Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 45: China Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 46: China 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 47: China Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 48: China Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 49: China 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

EUROPE
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 50: Europe Recent Past, Current & Future Analysis for
Dengue Testing by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 51: Europe Historic Review for Dengue Testing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 52: Europe 16-Year Perspective for Dengue Testing by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 54: Europe Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 55: Europe 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 56: Europe Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 57: Europe Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 58: Europe 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

FRANCE
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 59: France Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 60: France Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 61: France 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 62: France Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 63: France Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 64: France 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

GERMANY
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 65: Germany Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 66: Germany Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 67: Germany 16-Year Perspective for Dengue Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 68: Germany Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 69: Germany Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 70: Germany 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

ITALY
Table 71: Italy Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 72: Italy Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 73: Italy 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 74: Italy Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 75: Italy Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 76: Italy 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

UNITED KINGDOM
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 77: UK Recent Past, Current & Future Analysis for Dengue
Testing by Test Type - ELISA-Based Tests, RT-PCR Based Tests
and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 78: UK Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 79: UK 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 80: UK Recent Past, Current & Future Analysis for Dengue
Testing by End-Use - Hospitals, Diagnostic Centers, Public
Health Laboratory and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 81: UK Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 82: UK 16-Year Perspective for Dengue Testing by End-Use -
Percentage Breakdown of Value Sales for Hospitals, Diagnostic
Centers, Public Health Laboratory and Other End-Uses for the
Years 2014, 2023 & 2030

SPAIN
Table 83: Spain Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 84: Spain Historic Review for Dengue Testing by Test Type -
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 85: Spain 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 86: Spain Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 87: Spain Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 88: Spain 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

RUSSIA
Table 89: Russia Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 90: Russia Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 91: Russia 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 92: Russia Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 93: Russia Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 94: Russia 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 95: Rest of Europe Recent Past, Current & Future Analysis
for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR
Based Tests and Dengue IgG / IgM Rapid Test - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 96: Rest of Europe Historic Review for Dengue Testing by
Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue
IgG / IgM Rapid Test Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 97: Rest of Europe 16-Year Perspective for Dengue Testing
by Test Type - Percentage Breakdown of Value Sales for
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test for the Years 2014, 2023 & 2030

Table 98: Rest of Europe Recent Past, Current & Future Analysis
for Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 99: Rest of Europe Historic Review for Dengue Testing by
End-Use - Hospitals, Diagnostic Centers, Public Health
Laboratory and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 100: Rest of Europe 16-Year Perspective for Dengue
Testing by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Asia-Pacific for 2023 (E)
Table 101: Asia-Pacific Recent Past, Current & Future Analysis
for Dengue Testing by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 102: Asia-Pacific Historic Review for Dengue Testing by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 103: Asia-Pacific 16-Year Perspective for Dengue Testing
by Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2014, 2023 & 2030

Table 104: Asia-Pacific Recent Past, Current & Future Analysis
for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR
Based Tests and Dengue IgG / IgM Rapid Test - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 105: Asia-Pacific Historic Review for Dengue Testing by
Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue
IgG / IgM Rapid Test Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 106: Asia-Pacific 16-Year Perspective for Dengue Testing
by Test Type - Percentage Breakdown of Value Sales for
ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG / IgM
Rapid Test for the Years 2014, 2023 & 2030

Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 108: Asia-Pacific Historic Review for Dengue Testing by
End-Use - Hospitals, Diagnostic Centers, Public Health
Laboratory and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 109: Asia-Pacific 16-Year Perspective for Dengue Testing
by End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

AUSTRALIA
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Australia for 2023 (E)
Table 110: Australia Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 111: Australia Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 112: Australia 16-Year Perspective for Dengue Testing by
Test Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 113: Australia Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 114: Australia Historic Review for Dengue Testing by
End-Use - Hospitals, Diagnostic Centers, Public Health
Laboratory and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 115: Australia 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

INDIA
Dengue Testing Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in India for 2023 (E)
Table 116: India Recent Past, Current & Future Analysis for
Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR Based
Tests and Dengue IgG / IgM Rapid Test - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 117: India Historic Review for Dengue Testing by Test
Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue IgG /
IgM Rapid Test Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 118: India 16-Year Perspective for Dengue Testing by Test
Type - Percentage Breakdown of Value Sales for ELISA-Based
Tests, RT-PCR Based Tests and Dengue IgG / IgM Rapid Test for
the Years 2014, 2023 & 2030

Table 119: India Recent Past, Current & Future Analysis for
Dengue Testing by End-Use - Hospitals, Diagnostic Centers,
Public Health Laboratory and Other End-Uses - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 120: India Historic Review for Dengue Testing by End-Use -
Hospitals, Diagnostic Centers, Public Health Laboratory and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 121: India 16-Year Perspective for Dengue Testing by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Diagnostic Centers, Public Health Laboratory and Other End-Uses
for the Years 2014, 2023 & 2030

SOUTH KOREA
Table 122: South Korea Recent Past, Current & Future Analysis
for Dengue Testing by Test Type - ELISA-Based Tests, RT-PCR
Based Tests and Dengue IgG / IgM Rapid Test - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 123: South Korea Historic Review for Dengue Testing by
Test Type - ELISA-Based Tests, RT-PCR Based Tests and Dengue
IgG / IgM Rapid Test Markets - Independent Analysis of Annual

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05895944/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001